Johnson & Johnson Bullish On COVID-19 vaccine $jnjJ&J has tasked dozens of scientists to work on a vaccine for the disease, Paul Stoffels, a physician who is the New Brunswick, N.J., company's chief scientific officer, told CNBC.
"We are pretty confident we can get something made that will work and will stay active for the longer term," Stoffels told the business-news network.
Source Thestreet
